What is MAZE's dilution risk score?

MAZE has a latest available DilutionScore record of 35/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for MAZE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for MAZE?

DilutionWatch tracks 25 SEC filing types for MAZE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect MAZE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For MAZE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for MAZE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for MAZE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

MAZE Dilution Risk Score: 35/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

0

📊 Float Risk

30

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $200M remaining capacity

🔔 Track MAZE — Get forecast alerts →

Market Data

Market Cap$1.46B

Shares Outstanding55.55M

Float37.18M

Cash$411.09M

Debt$38.96M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 18.8% shares (2026Q1 vs prior)

169 institutional holders · 57.75M shares

#1 JANUS HENDERSON GROUP PLC 5.72M shares

#2 Frazier Life Sciences Management, L.P. 4.57M shares

#3 TRV GP IV, LLC 4.47M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.68M

Days to Cover15.9

% of Float15.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

xbrl XBRL WARRANT 2025-12-31

424B5 ATM 2026-04-22

8-K 8K EVENT 2026-04-22

4 INSIDER TRANSACTION 2026-04-02

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual MAZE Dilution Snapshot

Maze Therapeutics, Inc. (MAZE) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $200.0M.
Recent SEC activity tracked for MAZE: 424B5 on 2026-04-22; 8-K on 2026-04-22; 4 on 2026-04-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.